A Clinical Trial to Determine the Safety and Immunogenicity of Healthy Candidate MERS-CoV Vaccine (MERS002)

Clinical trial NCT04170829 · COMPLETED

Trial details

NCT number: NCT04170829
Sponsor: King Abdullah International Medical Research Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Middle East Respiratory Syndrome Coronavirus

Start date: 2019-12-17
Primary completion: 2020-11-26
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.